Structural, functional and immunogenic insights on Cu,Zn Superoxide Dismutase pathogenic virulence factors from Neisseria meningitidis and Brucella abortus by Pratt, AJ et al.
Pratt et al.  N. meningitidis and B. abortus Cu,ZnSODs  1 
 
Structural, functional and immunogenic insights on Cu,Zn Superoxide Dismutase pathogenic 1 
virulence factors from Neisseria meningitidis and Brucella abortus  2 
 3 
Ashley J. Pratta,b*, Michael DiDonatoa*, David S. Shina,b, Diane E. Cabellic, Cami K. Brunsa, 4 
Carol A. Belzerd*, Andrew R. Gorringee, Paul R. Langfordf, Louisa B. Tabatabaid*, J. Simon 5 
Krollf,  John A. Tainer b,g and Elizabeth D. Getzoffa# 6 
 7 
Department of Integrative Structural and Computational Biology and The Skaggs Institute for 8 
Chemical Biology, The Scripps Research Institute, La Jolla, CA, USAa; Life Sciences Division, 9 
Lawrence Berkeley National Laboratory, Berkeley, CA USAb; Chemistry Department, 10 
Brookhaven National Laboratory, Upton, NY, USAc; National Animal Disease Center, Ruminant 11 
Diseases and Immunology, Ames, IA, USAd; Public Health England (previously The Health 12 
Protection Agency), Porton Down, Salisbury, UKe; Section of Paediatrics, Department of 13 
Medicine, Imperial College London, St. Mary’s Campus, London, England, UKf; Department of 14 
Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 15 
Houston, TX, USAg 16 
 17 
Running Head: N. meningitidis and B. abortus Cu,ZnSODs 18 
 19 
#Address correspondence to Elizabeth D. Getzoff, edg@scripps.edu 20 
 21 
*Present address: Ashley J. Pratt, Health Interactions, San Francisco, CA, USA; Michael 22 
DiDonato, Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA; Carol 23 
JB Accepted Manuscript Posted Online 12 October 2015
J. Bacteriol. doi:10.1128/JB.00343-15
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Pratt et al.  N. meningitidis and B. abortus Cu,ZnSODs  2 
 
A. Belzer, Center for Veterinary Biologics-Policy, Evaluation and Licensing, Biotechnology, 24 
Immunology and Diagnostics, Ames, IA, USA; Louisa B. Tabatabai, Roy J. Carver Dept. of 25 
Biochemistry, Biophysics & Molecular Biology, Iowa State University, Ames, IA, USA.  26 
 27 
A.J.P. and M.D. contributed equally to this work. 28 
 29 
ABSTRACT. Bacterial pathogens Neisseria meningitidis and Brucella abortus pose threats to 30 
human and animal health worldwide, causing meningococcal disease and brucellosis, 31 
respectively. Mortality from acute N. meningitidis infections remains high despite antibiotics, 32 
and brucellosis presents alimentary and health consequences. Superoxide dismutases are master 33 
regulators of reactive oxygen, general pathogenicity factors and therefore therapeutic targets. 34 
Cu,Zn superoxide dismutases (SODs) localized to the periplasm promote survival by detoxifying 35 
superoxide radicals generated by major host antimicrobial immune responses. We discovered 36 
that passive immunization with an antibody directed at N. meningitidis SOD (NmSOD) was 37 
protective in a mouse infection model. To define the relevant atomic details and solution 38 
assembly states of this important virulence factor, we report high-resolution and X-ray scattering 39 
analyses of NmSOD and SOD from B. abortus (BaSOD). The NmSOD structures revealed an 40 
auxiliary tetrahedral Cu-binding site bridging the dimer interface; mutational analyses suggested 41 
that this metal site contributes to protein stability, with implications for bacterial defense 42 
mechanisms. Biochemical and structural analyses informed us about electrostatic substrate 43 
guidance, dimer assembly and an exposed C-terminal epitope in the NmSOD dimer. In contrast, 44 
the monomeric BaSOD structure provided insights for extending immunogenic peptide epitopes 45 
derived from the protein. These collective results reveal unique contributions of SOD to 46 
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pathogenic virulence, refine predictive motifs for distinguishing SOD classes and suggest general 47 
targets for anti-bacterial immune responses. The identified functional contributions, motifs, and 48 
targets distinguishing bacterial and eukaryotic SOD assemblies presented here provide a 49 
foundation for efforts to develop SOD-specific inhibitors or vaccines against these harmful 50 
pathogens. 51 
 52 
IMPORTANCE. By protecting microbes against reactive oxygen insults, Cu,Zn superoxide 53 
dismutases (SODs) aid survival of many bacteria within their hosts. Despite the ubiquity and 54 
conservation of these key enzymes, notable species-specific differences relevant to pathogenesis 55 
remain undefined. To probe mechanisms that govern the functioning of Neisseria meningitidis 56 
and Brucella abortus SODs, we used X-ray structures, enzymology, modeling and murine 57 
infection experiments. We identified virulence determinants common to both homologs, 58 
assembly differences and a unique metal reservoir within meningococcal SOD that stabilizes the 59 
enzyme and may provide a safeguard against copper toxicity. The insights reported herein 60 
provide a rationale and basis for SOD-specific drugs and extension of immunogen design to 61 
target two important pathogens that continue to pose global health threats. 62 
 63 
INTRODUCTION 64 
 Superoxide dismutases are master scavengers of reactive oxygen species (ROS), which are 65 
unavoidable byproducts of aerobic life. ROS, such as superoxide anion (O2.-), H2O2 and HO. play 66 
critical and varied roles in biological processes ranging from aging and oncogenesis, to 67 
pathogenesis and antibiotic action (1-4). ROS act as signals at low levels but as cytotoxins at 68 
higher levels (3, 5-8), so virtually all aerobic (and many anaerobic) organisms have evolved 69 
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defenses for ROS detoxification. The superoxide dismutase enzymes, which catalyze dismutation 70 
of O2.- radicals, are one such important antioxidant defense (9, 10). Three structurally distinct 71 
families employ alternate oxidation and reduction of active-site metal ion cofactors (11) (Mn/Fe, 72 
Ni, or Cu coupled to Zn) to protect different subcellular compartments (10). Ubiquitous 73 
Cu,ZnSOD (herein after referred to as SOD) family members exhibit a Greek-key β-barrel fold 74 
(12, 13) and can exist as monomers, dimers or tetramers of distinct assemblies, depending on the 75 
particular enzyme (12, 14-17). All employ similar mechanisms to achieve their catalytic activity 76 
and remarkable diffusion-limited reaction rates (18-22). However, our comparative mechanistic 77 
analyses of the periplasmic SOD from Photobacterium leiognathi with the cytoplasmic 78 
eukaryotic SODs suggested that some functional properties of bacterial (historically termed 79 
prokaryotic or P-class) and eukaryotic (E-class) SODs (19) evolved independently. Notably, 80 
periplasmic SODs are one of several defenses used by pathogenic bacteria to protect themselves 81 
from the respiratory burst of their host’s innate immune response, and thus to support bacterial 82 
survival and replication within phagocytes (23-25).  83 
 Neisseria meningitidis and Brucella abortus are two major pathogens that continue to 84 
threaten public health and welfare. The opportunistic bacterium N. meningitidis colonizes the 85 
nasopharyngeal mucosa; its access to the blood can cause life-threatening infections. N. 86 
meningitidis is a leading cause of meningitis and septicemia, with an estimated 1.2 million cases 87 
of human meningococcal infection annually (26), but with non-uniform global distribution rates 88 
(27), serogroup prevalences (28) and affected populations (29). Another gram-negative species, 89 
B. abortus, is one of a handful of Brucella species producing the zoonotic disease brucellosis, 90 
characterized by abortion, predominantly in ruminant animals including cattle, bison, sheep and 91 
goats. Furthermore, although human brucellosis is well-controlled in the U.S. [~100 cases 92 
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reported annually], more than half a million new cases are diagnosed globally each year (30). 93 
Infection is mostly due to laboratory contact, animal handling or consumption of tainted meat or 94 
dairy products; human symptoms range from flu-like to arthritis, epididymal/testicular 95 
inflammation, endocarditis, hepatitis and/or meningitis (31). Brucellosis therefore remains a 96 
worldwide threat both to human health and to the livestock industry. Preventative strategies 97 
against meningococcal disease and brucellosis have been met with some recent success. 98 
Vaccines against the major N. meningitidis serogroups infecting humans are now available, 99 
although their use is not routine, and their long-term efficacy has not been fully established in all 100 
populations (32). Similarly, although several B. abortus vaccines are available for cattle and 101 
small ruminants, their efficacy is variable and not protective against all Brucella species, with 102 
some vaccines complicating serological testing and/or causing abortion in a percentage of 103 
animals (33, 34). Further, no vaccine against human brucellosis currently exists (35). Thus, 104 
research on understanding the host immune response to N. meningitidis and B. abortus is needed. 105 
 Cytoplasmic superoxide dismutases protect aerobic organisms from endogenous O2.--induced 106 
damage to cellular enzymes (3, 4), and periplasmic SODs protect bacteria from extracytosolic 107 
damage (36), which although less well characterized, can arise from O2.-  produced endogenously 108 
(37) or exogenously by phagosomal NADPH oxidases (38). Unsurprisingly, many pathogenic 109 
SODs are potent virulence factors (39-43). Previously, we found that N. meningitidis SOD 110 
(NmSOD) deletion mutants were much more sensitive than wild type (WT) to extracellularly 111 
generated O2.- in vitro (44). Further, NmSOD mutant strains had increased phagocytic uptake 112 
into monocytes/macrophages (45), and were also less virulent in mice (44). Similarly, B. abortus 113 
SOD (BaSOD) deletion mutants were found to be susceptible to O2.- mediated killing in vitro and 114 
by macrophages in mice (46) and exhibited decreased survival during initial phases of infection 115 
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(47). Furthermore our work found that immunization with a synthetic peptide derived from 116 
BaSOD was immunoprotective in mice (48). Supporting and extending these previous results we 117 
now show that neutralization of NmSOD with a monoclonal antibody (49), also protected mice 118 
during infection.   119 
 To better understand the molecular bases of virulence imparted by pathogenic SODs, we 120 
solved 7 high-resolution structures from N. meningitidis and B. abortus. By combining 121 
crystallography with small-angle X-ray scattering (SAXS) to obtain accurate structures, 122 
conformations and assemblies in solution (50), we found that NmSOD adopts a P-class dimeric 123 
assembly, whereas BaSOD functions as a monomer. An auxiliary Cu-binding site spanning the 124 
NmSOD dimer interface was found to contribute to enzyme stability and may promote survival 125 
of N. meningitidis within phagocytes. The Cu site geometries within the NmSOD and BaSOD 126 
structures indicate a mixture of oxidation states that promote SOD function within the 127 
phagosome. Our combined structural, mutational and biochemical analyses show that NmSOD 128 
K91 and K94 contribute to electrostatic substrate guidance to the catalytic Cu site. These data 129 
further highlighted motifs distinguishing P-class SODs from classic E-class SOD dimers. 130 
Collectively, these results expand our molecular-level understanding of bacterial SODs and 131 
suggest testable experimental and therapeutic strategies to target bacteria to prevent and treat 132 
pathogenesis. 133 
 134 
MATERIALS AND METHODS 135 
Protein expression and purification. NmSOD was overexpressed in Escherichia coli strain 136 
QC779 (51) by using the vector pJSK205 (44). E. coli in mid-log phase grown in LB medium 137 
were induced with 0.4 mM IPTG, and protein expression proceeded overnight. Overexpressed 138 
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SOD directed to the periplasm was isolated by osmotic shock using 20% sucrose, precipitation 139 
using 65% (w/v) ammonium sulfate and subsequent centrifugation. The pellet was resuspended 140 
in 20 mL H2O and dialyzed against H2O for 4 hours at 4°C. The sample was then centrifuged for 141 
30 min (8,000 x g), and CuSO4 was added to the supernatant to a final concentration of 1 mM. 142 
The supernatant was then heated to 65°C for 30 min and then centrifuged for 45 min (40,000 x 143 
g). The supernatant was dialyzed against 20 mM MES, pH 5.9, and loaded onto a POROS 20 HS 144 
(Applied Biosystems) cation exchange column. Protein was eluted with a linear NaCl gradient, 145 
and SOD-containing fractions were pooled and dialyzed into 20 mM Tris-HCl, pH 8.0, and then 146 
applied to a POROS 20 HQ (Applied Biosystems) anion exchange column. Protein was eluted 147 
with a linear NaCl gradient, and fractions containing SOD were pooled, concentrated and applied 148 
to a HiLoad 16/600 Superdex 75 PG (GE Healthcare) gel filtration column. Peak fractions were 149 
pooled, and metal reconstitution with Cu and Zn was carried by dialysis as previously described 150 
(52). BaSOD was purified as described previously (53, 54). SOD activity of the recombinant 151 
proteins was measured using a gel-based SOD assay as described (11), and active, metal-152 
reconstituted SOD aliquots were frozen in liquid nitrogen and stored at -80°C. NmSOD mutants 153 
(E73A, K91Q, K91E, K91Q/K94Q and K91E/K94E) were constructed in pJSK205 using the 154 
QuikChange site-directed mutagenesis kit (Agilent) and purified as described above for WT 155 
NmSOD. Human SOD (HsSOD) was prepared as described (55). 156 
 Protein analysis. Prior to SAXS analyses, analytical gel filtration was performed at 4°C on 157 
BaSOD, loaded at 9 mg/mL, and HsSOD, loaded at 10 mg/mL, onto a Superdex 75 10/300 GL 158 
column (GE Healthcare) in 20 mM Tris, pH 7.5, containing 500 mM NaCl with 2% glycerol. 159 
Molecular weight standards (Bio-Rad) were run in the same buffer for comparison. A similar 160 
elution profile for monomeric BaSOD was also obtained on a 120 x 2.5 cm Sepharose G-75 161 
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column using 10 mM sodium-potassium phosphate, pH 6.4, 150 mM NaCl.  162 
 For metal analysis, samples of NmSOD were digested with concentrated nitric acid for 2 163 
hours at 65° C, and were then diluted to 10% nitric acid with distilled H2O for Inductively-164 
Coupled Plasma Optical Emission Spectrometry (ICP-OES) analysis on a Vista-MPX 165 
Spectrophotometer (Varian). Metal content was determined from 3 independent wavelengths, by 166 
using standard curves for Cu and Zn (0.1 to 100 ppm). The protein concentrations of the samples 167 
prior to digestion were determined by UV absorbance, and were used together with the ICP-OES 168 
results to determine the metal:protein ratio for NmSOD samples.  169 
 Stability measurements were performed as described previously (56) by titration of purified 170 
WT and E73A NmSOD samples and WT HsSOD (final concentration of 20 μM) with guanidine-171 
HCl (from 0 to 7 M, in 0.5-M steps) in the presence of PBS, pH 7.4, subsequent vortexing and 172 
overnight incubation at room temperature, followed by circular dichroism (CD). The CD sample 173 
cell path length was 0.1 cm, and the ellipticities were measured at 218 nm in an AVIV model 174 
2o2SF stopped-flow CD spectrometer in kinetics mode. Three 30-second measurements were 175 
averaged to obtain the final values, and Equation 1 was used to convert the raw CD data into 176 
fraction unfolded (Fu) for normalization: 177 
(1) 178 
Yn and Yd are the intercepts of the lines through the lower and upper plateau regions (low and 179 
high denaturant concentrations), respectively, and Y is the CD value at a given concentration of 180 
guanidine-HCl. Data were plotted as fraction unfolded versus guanidine concentration by using 181 
Origin 5.0 (Microcal Software Inc.) and fit to a sigmoidal curve. Detailed analyses of the free-182 
energy changes were not included, as previous work suggests that WT SOD folding and 183 
unfolding are not entirely reversible because of metal binding (56). 184 
Pratt et al.  N. meningitidis and B. abortus Cu,ZnSODs  9 
 
 For pulse radiolysis measurements, all solutions were prepared using ultra-purified 185 
(Millipore) distilled water, and reaction rates of SOD with O2.- were measured using the 2-MeV 186 
Van de Graaff accelerator at Brookhaven National Laboratory. Dosimetry was calculated using 187 
the KSCN dosimeter with a molar extinction coefficient of 7950 M-1cm-1 for (SCN)2- and a G 188 
value of 6.13. The path length was 2 cm, and a radiation dose of 150-2000 rads was used, 189 
yielding 1-20 μM O2.- per pulse. All activity measurements were carried out using aqueous 190 
solutions containing 10 mM formate, 10 mM phosphate at 25° C. The first measurement was 191 
made in the absence of ethylenediaminetetraacetic acid (EDTA), and subsequent measurements 192 
were made after adding 10 μM EDTA. No difference was observed in disproportionation rate, 193 
ensuring that no free Cu was present to confound the results.  194 
 The radiolysis of water predominantly yields eaq-, OH and H. These radicals can be converted 195 
to O2.- radical by the following reactions: eaq- + O2 → O2.- ; OH/H + HCO2- → H2O/H2 + CO2-; 196 
and CO2- + O2 → O2.- + CO2. The disappearance of O2.- was followed spectroscopically at 260 197 
nm [ε(O2.-) = 1800 M-1cm-1 at 260 nm] in the absence and presence of micromolar concentrations 198 
of enzyme. EDTA and sodium formate were purchased from Sigma and monobasic potassium 199 
phosphate from Ultrex, JT Baker, Inc. Solution pH was adjusted by adding H2SO4 (double 200 
distilled from Vycor, GFC Chem. Co.) and NaOH (Puratronic, Alfa/Ventron Chem.). 201 
 The activities of BaSOD and bovine erythrocyte SOD (Sigma) were assessed by using the 202 
xanthine/xanthine oxidase system as previously described (57). 203 
 X-ray crystallography. Crystals of NmSOD (WT and mutants) and BaSOD were obtained 204 
from 2-2.3 M (NH4)2SO4, pH 6-8.0, and 100-200 mM KCl by using the hanging drop vapor 205 
diffusion method, with the exception of the NmSOD E73A mutant, which was crystallized from 206 
20% polyethylene glycol 3000, 50 mM Tris-HCl, pH 8.0. Prior to cryogenic cooling, crystals 207 
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were soaked in a solution of 20% (v/v) glycerol, 75% (w/v) saturated (NH4)2SO4, 50 mM Tris, 208 
pH 7.5, 50 mM NaCl, 0.1 mM EDTA, and 0.02% NaN3, except for NmSOD E73A, which was 209 
soaked in mother liquor plus 20% ethylene glycol. 210 
 Diffraction data for all crystals were collected at the Stanford Synchrotron Radiation 211 
Laboratory (SSRL). Table S1 lists the specific beamlines used for each dataset. Data reduction 212 
and processing were carried out using the HKL package (HKL Research, Charlottesville, VA). 213 
Initial phases for NmSOD and BaSOD were obtained by molecular replacement using AMoRE 214 
(58) with A. pleuropneumoniae SOD [ApSOD; RCSB Protein Data Bank (PDB) code: 2APS] 215 
and a monomer of S. typhimurium SodCI (PDB code: 1EQW), respectively. The best scoring 216 
repositioned models were refined in CNS (59). Each subunit was treated as a rigid body for the 217 
initial refinements, and then the structures were refined using torsion angle simulated annealing 218 
at 5,000 K. Following these initial stages, the refinement of the models proceeded through cycles 219 
of manual rebuilding in XFIT (60) into sigma-A–weighted  2Fo-Fc and Fo-Fc electron density 220 
maps, and then positional and temperature factor refinement. Composite-omit simulated 221 
annealing maps were calculated for fitting when needed. The maximum likelihood target 222 
function, bulk solvent corrections and anisotropic temperature factor corrections were used for 223 
the refinement cycles in CNS. Where resolution permitted, the structures were then further 224 
refined using SHELXL (61) and the same Rfree reflection set along with individual anisotropic 225 
temperature factors. PHENIX (62) was used in the final round of refinement for BaSOD. 226 
 Small-angle X-ray scattering (SAXS). Solution scattering data on WT NmSOD and 227 
BaSOD were collected at SIBYLS beamline 12.3.1 at the Advanced Light Source of Lawrence 228 
Berkeley National Laboratory (63). Both samples were subjected to size-exclusion 229 
chromatography using a Superdex 75 10/300 GL column (GE Healthcare) prior to SAXS 230 
Pratt et al.  N. meningitidis and B. abortus Cu,ZnSODs  11 
 
analysis. SAXS data were collected on 15-μL samples at 16˚C, using automated sample loading 231 
from a 96-well format and a MAR CCD 165 detector with a sample-to-detector distance of 1.5 232 
m. The X-ray wavelength (λ) was 1.03 Å, and the scattering vector q (q = 4π sin θ/λ, where 2θ is 233 
the scattering angle) range was ~0.01 to 0.32 Å− 1. X-ray exposures ranged from 0.5 to 5 seconds 234 
(for each sample and matching gel filtration buffer blank), and the scattering of the buffer was 235 
subtracted from that of the protein. NmSOD was analyzed at 1.18, 1.3 and 2.35 mg/mL in 236 
phosphate-buffered saline (pH 7.4) containing 2% glycerol, and profiles superimposed well. X-237 
ray exposure data for the 1.3 mg/mL sample were used for merging and further analyses. BaSOD 238 
was run at 0.85 and 1.7 mg/mL in 20 mM Tris, pH 7.5, containing 500 mM NaCl with 2% 239 
glycerol, and data at 1.7 mg/mL were used for further analyses. Data sets were merged with 240 
PRIMUS (64). The P(r) function, Rg (real space approximation) and maximum distance Dmax 241 
were calculated with GNOM (65). DAMMIF (66) was used to generate 10 ab initio models each 242 
for NmSOD and BaSOD, which were then averaged using DAMAVER (67). Further details are 243 
tabulated in Table S2. FoXS (68) was used for theoretical profile computation and data fitting.  244 
 Molecular image rendering and modeling. PyMOL (Schrodinger, LLC) and Chimera (69) 245 
were used for generating structural images. The ClustalOmega server 246 
(http://www.ebi.ac.uk/Tools/msa/clustalo/) was used for sequence alignment. Normal mode 247 
analysis (NMA) models were generated using default settings on the elNémo server (70). 248 
 Structural coordinates. The coordinates described in this paper were deposited into the 249 
PDB: NmSOD (2AQN), NmSOD E73A (2AQP), NmSOD K91Q (2AQR), NmSOD K91E 250 
(2AQQ), NmSOD K91Q/K94Q (2AQT), NmSOD K91E/K94E (2AQS) and BaSOD (4L05). 251 
SAXS data were deposited into the BIOISIS repository (bioisis.net) using codes NMSODP and 252 
BASODP. 253 
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Antibody, bacterial strains and animal studies. The mouse monoclonal antibody HD1 was 254 
previously described (49). N. meningitidis MC58 (B:15:P1.7,16-2, ST-74, cc32) wild type and 255 
sodC knockout strains were cultured as described (44), and Western blotting was used to detect 256 
binding of HD1 to N. meningitidis protein extracts separated by denaturing or non-denaturing gel 257 
electrophoresis. Mice were challenged with 2 x 106 cfu intraperitoneal N. meningitidis co-258 
administered with or without HD1 antibody, as described previously (44). Survival was 259 
monitored for 4 days post infection. All animal-related studies were conducted under guidelines 260 
approved by the IACUC of the USDA National Animal Disease Center or by the Home Office, 261 
UK. 262 
NmSOD deletion mutants and HD1 epitope analysis. NmSOD deletion constructs were 263 
constructed by PCR. The encoded protein sequence of the C-terminal deletion mutant (lacking 9 264 








Deletion mutants were expressed in E. coli as described above. To confirm gene expression, 273 
RNA was prepared, and RT-PCR was performed using oligonucleotide primers for the respective 274 
sodC genes. As previously reported, immobilized metal affinity chromatography can be used to 275 
purify histidine-rich SOD samples (71). Whole cell lysates were applied to cobalt-Talon resin 276 
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(Clontech), and activity of the eluted NmSOD samples was assessed as described previously 277 
(44). Western blotting was used to detect binding of HD1 to deletion mutants. 278 
 279 
RESULTS 280 
Anti-SOD antibody provides protection from N. meningitidis infection. To test the 281 
hypothesis that NmSOD is a virulence factor that protects meningococci from free-radical 282 
mediated host defenses, we examined the ability of a monoclonal anti-SOD antibody to passively 283 
protect mice against N. meningitidis challenge. Passive immunity provides immediate, rather 284 
than delayed, protection against infection, and is currently used for post-exposure prophylaxis for 285 
chicken pox (Varicella Zoster) and rabies in humans (72, 73). In our experiments, mice were 286 
challenged with a dose of 2 x 106 cfu of N. meningitidis (MC58), with or without co-287 
administration of the monoclonal NmSOD-reactive antibody HD1 (49), and subsequently 288 
monitored for survival. Our results demonstrated that this NmSOD-neutralizing antibody 289 
conferred a robust level of passive protection, with a survival rate of 100% in HD1-treated mice 290 
at 4-days post-infection (Fig. 1).  291 
 N. meningitidis Cu,Zn superoxide dismutase (NmSOD) conserves P-class dimer 292 
assembly. To better understand potential determinants of virulence for NmSOD, we solved the 293 
structure of the enzyme to 1.4-Å resolution (Table S1; Rwork = 12.8%, Rfree = 19%). Each subunit 294 
of the NmSOD homodimer conserves the SOD Greek-key β-barrel fold (Figs. 2 and 3): the root-295 
mean-square-deviations (RMSDs) of Cα atoms between NmSOD and bacterial SOD structures 296 
from Actinobacillus pleuropneumoniae (PDB code: 2APS) (74), Haemophilus ducreyi (1Z9N) 297 
(75), P. leiognathi (1YAI) (19, 76, 77), Salmonella typhimurium SodCI (1EQW) (78) and 298 
Yersinia pseudotuberculosis (2WWO) were all < 1 Å. As suggested by comparative structural 299 
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analyses of bacterial SOD sequences (Fig. S1) (74), subunit interface residues characteristic of 300 
dimeric P-class SODs were conserved in NmSOD (Fig. 3C), together with the ring-like assembly 301 
of buried water molecules (Figs. 2A and 3B). The surface buried by the dimer interface was 302 
calculated with PISA to be to be ~915 Å2. This P-class dimer is the best-represented 303 
crystallographic assembly for bacterial SODs in the Protein Data Bank thus far (Table S3). 304 
 To determine whether the biological state of the enzyme is accurately represented within the 305 
crystal, we used SAXS, which allows determination of conformations and assemblies for 306 
macromolecules in solution (79, 80). NmSOD SAXS data agreed with scattering profiles 307 
predicted from the crystallographic dimer, with a χ2free value (80) of 1.83 (Fig. 2D). The SAXS-308 
derived electron pair distribution [P(r) plot] (Fig. 2E) and molecular envelope models (Fig. 2F, 309 
left) further indicated an elongated shape consistent with the crystal structure. SAXS 310 
measurements also indicated a marginally lower-than-average particle density (81) for NmSOD 311 
(Table S2), with small deviations in the profile fit for scattering angles > q = 0.17 (Fig. 2D). 312 
These observations, also supported by normal mode analyses (Fig. S2) and elevated (atomic 313 
displacement parameters, ADP; B-factors), suggested considerable protein flexibility in 314 
NmSOD, particularly within bacterial SOD-specific loop regions (Fig. S3). 315 
 Electrostatic guidance in NmSOD speeds enzymatic activity. The crystal structure of 316 
NmSOD revealed that seven, conserved, active-site residues mediate Cu (histidines H79, H81, 317 
H104 and H160) and Zn (H104, H113, H122 and aspartic acid D125) coordination (Figs. 2C and 318 
S1). The catalytic Cu site has trigonal planar ligation geometry characteristic of reduced Cu(I), as 319 
was also found in structures of E-class yeast SOD (PDB code: 2JCW) (82) and P-class A. 320 
pleuropneumoniae SOD (PDB code: 2APS) (74), among others. The average Cu(I)–ligand bond 321 
lengths (± standard deviation) for the 3 NmSOD subunits in the asymmetric unit were 2.0 ± 0.0, 322 
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2.0 ± 0.1 and 2.0 ± 0.1 Å for H79, H81 and H160, respectively. The 3.1 ± 0.1-Å separation 323 
distance between Cu(I) and H104 indicates a broken bond to the bridging histidine, which ligates 324 
both metal ions in the oxidized enzyme. The Zn site exhibits a characteristic, distorted tetrahedral 325 
geometry, with average bridging H104-Zn distance of 2.0 ± 0.1 Å. 326 
 Analyses of SOD structures and sequences suggested that residues promoting electrostatic 327 
guidance in bacterial SODs lie across the active-site channel from the functionally equivalent 328 
electrostatic loop (linking β-strands 7 and 8) of eukaryotic SODs (19, 74). The functionally 329 
equivalent NmSOD residues predicted from our structural alignment (Fig. S1) include K91, E92 330 
and K94, located in a bacterial SOD sequence insertion (relative to eukaryotic SODs, Fig. 3C), 331 
forming a protruding β-hairpin at the ends of P-class dimer (Fig. 2A). We constructed mutants to 332 
either neutralize (K91Q and K91Q/K94Q) or reverse (K91E and K91E/K94E) one or both 333 
charges, and then used pulse radiolysis to evaluate the rate constants over a wide pH range (Fig. 334 
4A). We found that while charge neutralization at residue 91 alone did not substantially affect 335 
the rate constant, the K91Q/K94Q double mutant reacted 1.5-fold more slowly than WT. 336 
Moreover, reversing the charge at one or both residues decreased the rate constant substantially: 337 
At pH 7, the rate constants for K91E and K91E/K94E dropped 2.5-fold and 5-fold, respectively, 338 
relative to that for WT (Fig. 4A). Mirroring analogous studies on the HsSOD enzyme (18), these 339 
results confirmed the involvement of these two lysine residues in the electrostatic attraction of 340 
O2.- substrate to the active-site Cu ion in NmSOD and suggest a greater contribution for K94 than 341 
was seen for the equivalent residue in the monomeric E. coli enzyme (83). We also determined 342 
structures of these NmSOD electrostatic mutants at resolutions ranging from 1.65 to 1.8 Å (Fig. 343 
S3 and Table S1). Apart from mutation site alterations (most notable in K91E/K94E), slight 344 
subunit rotations and modestly increased ADPs (Fig. S3B), all structures were similar to WT 345 
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(Fig. S3A). These findings suggest that fine-tuning of electrostatic guidance is not accomplished 346 
through major structural rearrangements in NmSOD, and also confirm that the active site 347 
geometry is maintained in the mutants described above. 348 
  349 
 A stabilizing, auxiliary copper site bridges the NmSOD dimer interface. Metal sites are 350 
key contributors of activity and stability in SODs. Surprisingly, ICP-OES analyses of NmSOD 351 
indicated a stoichiometry of 1.5 Cu ions per subunit, matching one in each active site and one 352 
additional Cu ion per dimer. Correspondingly, in the X-ray structures (Figs. 2 and 4), we 353 
observed a unique, cross-dimer, Cu-binding site, evidenced by a strong (> 10σ) electron density 354 
peak in omit maps (Figs. 2A, S4B, 4C, top, and 4D). This auxiliary Cu is tetrahedrally ligated by 355 
H133 and E73 from each subunit (Figs. 4C, top, and 5A), implying an oxidized Cu(II) state. 356 
Thus, the NmSOD structure appears to contain both oxidized and reduced Cu sites, suggesting 357 
that the geometry of these sites tunes their redox activity; the distorted active-site Cu ion 358 
geometry evolved to promote redox chemistry for catalysis, whereas the less-constrained 359 
geometry of the auxiliary site allows the Cu ion to remain oxidized, despite equivalent exposure 360 
to reduction by free electrons during the X-ray diffraction data collection. Interestingly, 361 
structural superposition of NmSOD with H. ducreyi SOD (HdSOD), which contains an unique 362 
heme-binding site (75, 84)  revealed that the auxiliary Cu and heme Fe align, each forming an 363 
unusual cross-dimer bridge  (Fig. 4D-E). 364 
 To probe the functional contributions of the auxiliary Cu in NmSOD, we constructed the 365 
E73A point mutant, which removed 2 ligands from the cross-dimer Cu-binding site. We found 366 
no major oligomeric state (Fig. S4A) or catalytic differences between WT and E73A NmSOD, 367 
aside from a slight rate increase for E73A NmSOD above pH 8.5 (Fig. 4A). Next, to assess 368 
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whether the auxiliary Cu-binding site affects protein stability, we used circular dichroism (CD) 369 
spectroscopy to monitor NmSOD unfolding, under increasing concentrations of guanidine-HCl 370 
(Gu-HCl) (Fig. 4B). Generally, the unfolding curves for WT and E73A NmSOD were less steep 371 
than that for WT HsSOD, suggesting somewhat less concerted and cooperative unfolding for the 372 
bacterial enzyme. WT NmSOD and HsSOD displayed similar unfolding, with the NmSOD 373 
unfolding midpoint marginally greater (4.3 M Gu-HCl) than that of HsSOD (3.9 M). E73A 374 
unfolded at a slightly lower concentration of guanidine-HCl (3.6 M), indicating a modest loss of 375 
stability upon removal of Cu-binding E73. Unfolding of E73A also began at lower Gu-HCl 376 
concentrations than for either WT enzyme, and complete unfolding of WT NmSOD required 377 
higher Gu-HCl concentrations, relative to WT HsSOD or E73A NmSOD. Overall, these results 378 
suggest that although the auxiliary, dimer-spanning, Cu-binding site it is not necessary for dimer 379 
formation, it stabilizes the NmSOD assembly.  380 
 To understand how E73 imparts stability at the atomic level, we determined the 381 
crystallographic structure of E73A NmSOD to 1.3-Å resolution (Fig. 4C, bottom and Table S1; 382 
Rwork = 13.5, Rfree = 18.3). We found that the E73A NmSOD structure was generally similar to 383 
WT, but with no Cu bound in the vicinity of A73 (Fig. 4C, bottom). Instead, Cu ions appeared to 384 
mediate crystal contacts between H148 of one E73A NmSOD dimer and its symmetry mate (Fig. 385 
S4C). In contrast, mutation of electrostatic guidance residues did not affect the position of the 386 
auxiliary Cu ion in NmSOD (Fig. S3B), despite differing crystal symmetries and solvent 387 
contents (Table S1). These results suggest that the decreased stability arises from the lack of Cu 388 
binding, rather than from gross structural differences. 389 
 B. abortus Cu,Zn superoxide dismutase (BaSOD) has a conserved active site but 390 
monomeric assembly. Sequence alignments suggested that BaSOD, in contrast to NmSOD, 391 
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lacks canonical P-class dimer interface residues (Fig. S1) (74), and NMR results suggested 392 
BaSOD was a monomer (53). Informed by these observations, we proceeded to solve the high-393 
resolution X-ray crystallographic structure of BaSOD to 1.1-Å resolution (Table S1; Rwork = 394 
11.3, Rfree = 13.8). Notably, the active-site electron density of BaSOD revealed a mixture of 395 
oxidized and reduced structural conformations, reflective of the enzyme mechanism, so we 396 
modeled 2 positions each for the Cu ion and its bridging histidine (Fig. 2C, bottom). In the 397 
oxidized state, the bridging H73-Cu(II) bond is 2.0-Å long, and upon reduction, active-site 398 
movements shift the H73 side chain 3.1 Å away from Cu(I) such that H73 can form a 2.5-399 
Å hydrogen bond with a bound water molecule within the active site. The bond distances 400 
between the 2 alternate H73 conformations and the Zn ion are 1.9 and 2.1 Å. For the remaining 401 
ligands, the Cu(I)–ligand bond lengths are 2.0, 2.0 and 2.1 Å for H48, H50 and H128, 402 
respectively, and Cu(II)–ligand bond lengths are 2.1, 2.2 and 2.2 Å for H48, H50 and H128, 403 
respectively. Like NmSOD, BaSOD retains the overall Greek-key β-barrel fold conserved in 404 
other Cu,ZnSODs (Fig. 2B) (85), albeit with only one BaSOD molecule contained within the 405 
asymmetric unit. 406 
 B. abortus SOD is active as a monomeric enzyme. BaSOD exhibited activity similar to that 407 
of the well-studied bovine SOD dimer (Fig. S5A), even though the crystal structure suggested 408 
that BaSOD is monomeric. To confirm this stoichiometry, we used both gel filtration 409 
chromatography (Fig. S5B) and SAXS (Fig. 2D-E), which ascertained the monomeric biological 410 
assembly of the enzyme in solution. The SAXS profile (Fig. 2D) revealed that the BaSOD 411 
monomer in the crystallographic asymmetric unit matches the shape and assembly in solution 412 
(χ2free value of 1.30), and is distinct from the dimeric NmSOD SAXS profile; the P(r) plot and ab 413 
initio envelopes for BaSOD in solution (Fig. 2E-F) indicated a smaller, more globular shape that 414 
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fit the monomeric crystallographic structure. Although diverse Cu,ZnSOD enzymes retain the 415 
same subunit fold and Cu-mediated chemistry, their quaternary assembly varies considerably, 416 
notably in bacteria (Table S3 and Fig. 3). Although SOD monomers are less well represented 417 
than P-class dimers in the PDB, the BaSOD structure is similar to monomeric homologs E. coli 418 
SOD (PDB code: 1ESO (86), with an R.M.S.D. of < 0.6 Å), S. enterica SodCII (2K4W (87), 419 
R.M.S.D. ~1.4 Å) and Bacillus subtilis SOD-like protein (1S4I (88), R.M.S.D. ~1.08), with 420 
discrepancies predominantly in loop regions. Overall, monomeric SODs are stable and active, 421 
despite the prevalence of their dimeric counterparts. 422 
 Epitope mapping onto NmSOD and BaSOD structures. The crystal structures and 423 
resulting structure-based sequence alignments of NmSOD and BaSOD enabled us to investigate 424 
the determinants of virulence within these enzymes. The anti-SOD antibody HD1 (49) bound 425 
strongly to NmSOD in denaturing or non-denaturing Western blots of N. meningitidis protein 426 
extracts, and we established that no cross-reactive meningococcal products bound HD1 by using 427 
a sodC knockout strain. Given the cross-reactivity of HD1 to several known bacterial SODs and 428 
(49) and the high sequence conservation in the C-terminus, we hypothesized that this region 429 
might contain the HD1 epitope. To test this prediction, we created 2 NmSOD deletion mutants 430 
(see Materials and Methods): a 9-residue C-terminal deletion mutant (which disrupts the 431 
disulfide loop) and an internal deletion mutant that retained this C-terminal sequence (Fig. S6).  432 
The mutant proteins were expressed in E. coli, and then tested for SOD activity and HD1 433 
reactivity. Both proteins lacked dismutase activity, but only the internal deletion mutant bound 434 
HD1 in Western blots. These binding results suggest that the C-terminal residues contribute to 435 
the NmSOD epitope recognized by the HD1 antibody, which protected mice from succumbing to 436 
N. meningitidis infection (Figs. 1 and S6). The 9-residue C-terminal NmSOD sequence 437 
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(PRMACGVIK) includes 6 residues conserved across domains of life, as well as variable 438 
residues (xRxACGVIx) that may dictate the reactivity of HD1. In NmSOD, the first and third 439 
variable residues of this sequence flank the invariant active-site arginine to form a “PRM” motif 440 
shared by HD1-reactive (49), dimeric SODs from Actinobacillus and Haemophilus. In contrast, 441 
the monomeric BaSOD and E. coli SODs do not react with HD1 (49) and lack the “PRM” motif 442 
within the proposed C-terminal epitope of HD1 (Fig. S6). 443 
 To understand the structural basis for protective peptide immunogens in BaSOD, we mapped 444 
the peptide immunogens we had previously tested (48) onto our structure (Fig. S7). The 445 
protective BaSOD peptide (residues 56-67, Fig. 3C, underlined in red) occurs in the loop insert 446 
specific to the bacterial SODs (Fig. 3C, boxed) that contains electrostatic guidance residues K60, 447 
D61 and K63. Comparison of this loop in the bacterial and HsSOD structures (and by analogy 448 
murine SOD) revealed an extended protrusion in BaSOD (and NmSOD) (Fig. 6). Therefore, 449 
antibody binding to this BaSOD epitope would be expected to disrupt electrostatic guidance 450 
and/or sterically hinder access to the active site. In contrast, the 2 non-protective peptides span 451 
residues 117-131 and 130-143 (Fig. S7, orange). The former encompasses all of strand β7 452 
[numbered going around the β-barrel (74)] and part of the core β-barrel framework forming the 453 
back wall of the active site (containing Cu ligand H128). This epitope is only partly solvent-454 
exposed; therefore, an immune response to the intact protein might not be expected. The latter 455 
non-protective peptide encompasses part of the loop connecting strand β7 to strand β8 (the 456 
electrostatic loop of eukaryotic SODs). This surface-exposed loop is adjacent to the active site, 457 
but is not critical to enzymatic functioning of bacterial SODs, so antibody binding may only 458 
modestly impact substrate entry. These BaSOD peptide vaccines were developed based on 459 
hydrophobicity, flexibility and antigenicity predictions, in the absence of any structural 460 
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information (48). The high-resolution structures presented here provide detailed, specific 461 
frameworks to improve targeting for the development of more effective vaccines. 462 
 463 
DISCUSSION 464 
Structural insights differentiating bacterial and eukaryotic Cu,ZnSODs. The oligomeric 465 
state of a protein can control its physicochemical properties, behavior and biological interactions, 466 
and thus is key for informed design of drugs and vaccines. For example, HsSOD polymers 467 
genetically engineered for therapeutic use as anti-inflammatories exhibited a desirable extended 468 
serum half-life (89); conversely, loss of assembly specificity in mutant HsSODs was associated 469 
with toxic aggregation in the degenerative motor neuron disease Amyotrophic Lateral Sclerosis 470 
(ALS) (55, 56). Many distinct assemblies have been found for the Cu,ZnSOD subunit fold (Fig. 471 
3A): the bacterial P-class monomer and dimer, an alternative extended-loop dimer found in 472 
Mycobacterium tuberculosis SodC (90) (herein termed Loop or L-class) and the B. subtilis SOD-473 
like dimer (88) (Table S3); and in eukaryotes, a fungal monomer (91), the metazoan E-class 474 
dimer (12) and the dimer-of-dimers tetramer of extracellular SOD (17), as well as larger 475 
“dogbone” (12) and nanofilaments (92) assemblies of HsSOD dimers. Determining the natural 476 
biological assembly state from a crystallographic structure can be challenging, especially for 477 
SOD proteins, which display these different biological assemblies and many complex crystal 478 
packing arrangements. Therefore, complementary characterization in solution is crucial for 479 
accurately defining the physiological assembly state of a protein (93, 94), as we report here for 480 
the architecturally distinct virulence factors NmSOD and BaSOD (Fig. 2).  481 
 Exploitable physiological differences between bacterial and eukaryotic SODs stem from 482 
evolutionary structural dissimilarities. Here, based on our new structures, we identify sequence 483 
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motifs that discriminate among SOD homologs, assign stoichiometry and connect gene to 484 
function (Figs. 3C and S1). Two conserved motifs identify most CuZnSODs: a C-terminal 485 
RX(A/V/S)CGV(I/V) sequence (Figs. 3C and S1), and the active-site histidine pattern, notably 486 
the first 2 Cu-ligating histidines separated by a single hydrophobic residue. So, how are bacterial 487 
SODs distinguished from those of eukaryotes? First, only E-class enzymes conserve an aromatic 488 
(or hydrophobic) interface residue (F50 in HsSOD) followed by glycine, positioned 2 residues 489 
after the second Cu-ligating histidine, as well as a salt-bridging arginine (R79 in HsSOD), 490 
positioned immediately before the third Zn-binding histidine. Another feature is the C-terminal 491 
shift of the first disulfide bond cysteine, arising from a disulfide loop insertion in bacterial SODs. 492 
In P-class SODs, this cysteine is positioned 5 residues after the second Cu-ligating histidine, 493 
while in E-class SODs, it is 6 residues before the third Cu-ligating (bridging) histidine (Fig. 3C). 494 
In bovine and HsSODs, mutation of oxidation-prone free cysteines (near the N-terminus and 495 
Greek key connections) increased enzyme stability (12, 95). Notably, the P-class SODs lack free 496 
cysteines, which are selected against in the oxidizing periplasm (96, 97); this feature may 497 
contribute to the higher stability of NmSOD, relative to HsSOD (Fig. 4B). These insights extend 498 
our previous work detailing the molecular basis of the Greek key β-barrel evolution (98). 499 
 Given the diversity among microbial SODs, we also re-evaluated sequence and structural 500 
features characteristic of their different assembly states. L-class bacterial SODs are clearly 501 
differentiated from their P-class counterparts by a large insertion between the last 2 β-strands, 502 
but how are P-class dimers and monomers distinguished? P-class dimer interfaces generally 503 
conserve 4 buried aromatic or hydrophobic residues encircling a buried water ring (19, 74-76) 504 
(Fig. 3B and 3C, red): i) a lateral aromatic tryptophan or tyrosine (19, 74, 76, 78); ii) its cognate 505 
hydrophobic residue (19, 74, 76, 78), typically V or L, in the opposing monomer; iii) a YG motif 506 
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present in a majority of P-class dimers, which forms hydrophobic packing interactions and a 507 
hydrogen bond with an adjacent D at the bottom of the interface (which variably interacts with 508 
residues adjacent to the YG) (19, 74, 76, 78), and iv) a hydrophobic amino acid, which 509 
contributes to a hydrophobic cluster toward the top of the interface through interactions with 1 510 
(19, 76, 78) or more of its cognate residues in the opposing monomer. This cluster is located just 511 
below the auxiliary copper site in NmSOD (Fig. 3B). In P-class monomers, however, these 4 512 
conserved residues are frequently replaced with hydrophilic or hydrogen-bonding residues 513 
expected to destabilize hydrophobic interface packing (86), which was echoed experimentally by 514 
characterization of monomer-dimer hybrid proteins (99). These discriminating features identified 515 
from SODs of known structure suggest that the assembly class is predictable from sequence data 516 
(e.g. for uncharacterized archaeal SOD-like sequences or SODs from bacterial and eukaryotic 517 
viruses that conserve P-class (41) and E-class (100, 101) features, respectively). Identification, 518 
testing and refinement of these predictive motifs show promise for distinguishing the SODs of 519 
pathogens from those of their hosts, for therapeutic targeting applications.  520 
 Significance of the auxiliary Cu site in NmSOD. The need to control ROS has been a 521 
major driver of pathogenic and eukaryotic evolution, with the extreme example of glutathione 522 
peroxidase incorporation of selenocysteine, via an altered stop codon (102). Cu-containing SODs 523 
evolved to protect against rising oxygen (103), thus allowing bacterial SODs to also serve as 524 
virulence factors protecting pathogens from ROS-mediated host defenses. Host phagocytes use 525 
an arsenal of strategies to combat bacterial invaders during engulfment and phagosomal 526 
maturation stages of infection (Fig. 5B). During the latter process, toxic levels of phagosomal Cu 527 
may contribute to bactericidal activity (104), in part through ROS production and resulting 528 
oxidative damage (105). N-terminal histidine- and/or methionine-rich Cu(I/II) and/or Zn(II) 529 
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binding motifs in H. ducreyi and A. pleuropneumoniae SODs (71, 106, 107) may facilitate Cu 530 
acquisition or active-site transfer in scarce conditions (106), and also serve to protect these 531 
pathogens from phagosomal Cu toxicity. Likewise, auxiliary metal (nickel and bismuth) binding 532 
sites in other bacterial proteins are implicated in metal buffering, sequestration and toxicity 533 
(108). The novel metal site at the NmSOD interface was unexpected, but is consistent with 534 
observations that microbial metalloproteomes are still incompletely characterized (109). These 535 
findings further our understanding of metal-buffering properties in key bacterial proteins. 536 
 Interestingly, the auxiliary NmSOD Cu site corresponds to the heme-binding site in HdSOD 537 
(75, 84) (Fig. 4D-E), with HdSOD ligands H64 and H124 positionally equivalent to NmSOD 538 
E73 and H133, although the HdSOD heme is bound asymmetrically. Since H. ducreyi cannot 539 
synthesize heme and must obtain it from its host, HdSOD was proposed to be involved in heme 540 
metabolism as a sensor or buffer against heme toxicity (75). Based on these similarities, we 541 
tested heme-binding to NmSOD in vitro by using the same procedure (84) but found no evidence 542 
of bound heme. The auxiliary Cu- and heme-binding residues are not generally conserved in 543 
other SODs (Fig. S1, red squares), highlighting the uniqueness of this interface region as a 544 
potential antimicrobial target. The solvent-exposed cavity (Figs. 3B and 5A) formed between the 545 
auxiliary Cu site and the rest of the P-class dimer interface makes an attractive target for small 546 
molecule binding. For instance, an inhibitor targeted to this cavity could disrupt binding of the 547 
auxiliary Cu, thus compromising NmSOD stability. CO or NO binding to the heme in HdSOD 548 
did in fact induce conformational rearrangements of that enzyme, including altered active-site 549 
accessibility (110). Similarly, active-site accessibility and catalysis were affected by interface 550 
substitution mutants in the P. leiognathi SOD P-class dimer (111). The slightly extended pH 551 
range over which NmSOD E73A was active (Fig. 4A) suggests that NmSOD interface 552 
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modulation might also alter catalytic activity through allosteric effects. Thus, our NmSOD 553 
structures (Figs. 4C, 5A and S3-S4) provide an experimental basis for testing the impacts of the 554 
auxiliary Cu site, not only on enzyme activity and stability, but also on virulence and survival of 555 
this deadly pathogen. 556 
 Protective immunity via targeting of bacterial SODs. The monoclonal anti-SOD antibody 557 
HD1 recognizes not only meningococcal SODs, but also ApSOD and Haemophilus SOD (49). 558 
Here, we showed that HD1 conferred an impressive level of passive protection against infection 559 
of mice with different strains of serogroup B meningococci (Fig. 1), and that the NmSOD C-560 
terminus is critical for HD1 binding (Fig. S6). Although the epitope recognized by HD1 has not 561 
yet been comprehensively characterized, this antibody serves as both a useful experimental tool 562 
and a proof of concept for protective immunization. In contrast, we were unable to confer active 563 
protection in mice using a standard preparation of recombinant NmSOD. Thus, re-engineered 564 
NmSOD or peptide fragments may provide useful components for broadening coverage of 565 
existing vaccine formulations (112). Since the most common serogroups of N. meningitidis all 566 
express the sodC gene (44) and NmSODs are highly sequence-conserved, a SOD immunogen 567 
might also improve vaccine efficacy against related microbes. 568 
Current animal vaccines for brucellosis are unsuitable for human use, and accidental 569 
exposure to these brucellosis strains can result in adverse effects (113). The illegitimate use of 570 
Brucella as a potential bioterrorism agent also underscores the need for further intervention 571 
strategies (114). Periplasmic SOD from B. abortus, a major cause of brucellosis, was identified 572 
as a major cattle serum-reactive protein that might serve as a Brucella vaccine immunogen (16, 573 
48, 54). Vaccination with attenuated SOD-deletion strains of B. abortus prevented abortion in 574 
cattle (115), and vaccination with BaSOD-overexpressing bacteria (116, 117), liposome-575 
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encapsulated BaSOD or nucleic acid BaSOD vaccines (118, 119) also conferred protective 576 
advantage. Previous efforts identified one of three tested peptide immunogens from the BaSOD 577 
sequence as protective when administered in mice (48). Comparative high-resolution structural 578 
analyses of pathogen vs. host proteins enable identification of peptides that promote 579 
immunogenicity against pathogens, while minimizing production of host autoantibodies (Fig. 580 
S7), a major impetus for this work.  581 
 Antigenic targets from new structures. Our structures provide direct insights for potential 582 
peptide-based vaccination efforts against both N. meningitidis and B. abortus. These P-class 583 
SODs contain protruding surface-exposed loops that include insertions relative to E-class SODs 584 
(Fig. 6C). Immunogenic peptide BaSOD A56-A67 (48) represents part of such a loop (Fig. S7). 585 
Extending this peptide to N52-A67 (and by analogy NmSOD N83-G98) to incorporate the entire 586 
loop exposed in bacterial SODs, but buried in the mammalian E-class dimer interface, might 587 
elicit an improved response. BaSOD K6-K17 (equivalent to NmSOD K37-K48) represents 588 
another such loop. Lastly, the C-terminal NmSOD sequence implicated in HD1 binding might 589 
provide another immunogen (Fig. S6), as it also is exposed in P-class SODs, but buried in the E-590 
class dimer interface. The flexibility inherent in these sequences (Fig. 6B and Fig. S2) is 591 
important for the interactions of antibody complementarity-determining regions and protein 592 
epitopes (120-122). However, to maintain appropriate secondary structure, peptide immunogens 593 
may benefit from structural restraints, designed based on hydrogen-bonding, loop conformations, 594 
and attachment to the parent protein, as revealed by our NmSOD and BaSOD structures.  595 
 Conclusions. The still-evolving vaccination programs and suboptimal treatments against N. 596 
meningitidis and B. abortus (34, 123) underscore the need for novel, additional approaches to 597 
intervene in pathogenesis, especially given the emergence of antibiotic resistance. Vaccine and 598 
Pratt et al.  N. meningitidis and B. abortus Cu,ZnSODs  27 
 
drug design strategies directed at periplasmic SOD virulence factors (124) benefit from detailed 599 
knowledge of structures, assemblies and mechanisms of SODs from bacteria and their hosts. 600 
Both microbial and eukaryotic SODs function as master regulators of ROS and can contribute to 601 
human disease. In HsSOD ALS mutants, Cu deficiency and flexibility are associated with mis-602 
assembly, aggregation and clinical severity (55). Here, we show that SODs of pathogenic 603 
bacteria differ from SODs of their hosts by several targetable means: distinct assembly states, 604 
flexible insertions and, sometimes, auxiliary Cu sites that enhance stability. This work provides a 605 
framework for predictive understanding of SODs from sequence, highlights similarities and 606 
differences between bacterial and eukaryotic enzymes, and describes notable determinants of 607 
virulence, which can serve as therapeutic targets. 608 
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FIGURE LEGENDS 998 
FIG 1 NmSOD-reactive monoclonal antibody HD1 protects mice from N. meningitidis 999 
serogroup B infection. Mice were challenged with bacteria co-administered with the antibody 1000 
(HD1) or without (control). As indicated by survival data, HD1 conferred passive protection 1001 
against experimental infection. 1002 
 1003 
FIG 2 Three-dimensional X-ray structures of N. meningitidis Cu,ZnSOD (NmSOD, gold) and B. 1004 
abortus Cu,ZnSOD (BaSOD, blue). (A) NmSOD is a P-class homodimer of conserved Greek-1005 
key β-barrel SOD subunits (β-strands in gold, α-helices in green). Buried interface water residues 1006 
are depicted as red spheres, disulfide positions by S-S and active-site Cu and Zn ions by bronze 1007 
and silver spheres, respectively. (B) BaSOD is a monomer with the same conserved SOD fold 1008 
(β-strands in blue, α-helices in purple). (C) Close-up of NmSOD (top) and BaSOD (bottom) 1009 
active sites with metal-binding histidine and aspartic acid ligand side chains shown and the Cu 1010 
ligands labeled. The redox-active Cu site and bridging histidine are modeled in two positions 1011 
(oxidized and reduced) in BaSOD. (D) Experimental SAXS data (gold and blue) fit SAXS 1012 
profiles (red and black) simulated from the crystallographic assemblies (NmSOD dimer and 1013 
BaSOD monomer, respectively). Residuals (experimental/model intensity ratio) are depicted 1014 
below profiles. (E) Real-space electron pair distributions for NmSOD and BaSOD reveal 1015 
significant differences in overall shape and dimensions of these two enzymes in solution, 1016 
consistent with NmSOD P-Class dimer assembly and monomeric BaSOD. (F) X-ray structures 1017 
of NmSOD (left) and BaSOD (right) docked into ab initio envelopes modeled from SAXS data 1018 
show agreement between crystalline and solution X-ray data. 1019 
 1020 
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FIG 3 Comparative structural assemblies of SODs and SOD homologs are linked to sequence 1021 
motifs. (A) Distinct quaternary arrangements of bacterial and eukaryotic Cu,ZnSODs (SODs) 1022 
and SOD homolog. Top and side views (relative to the β-barrel) depict Cα traces for 4 distinct, 1023 
representative dimers, superimposed using one reference subunit (red) each: P-class N. 1024 
meningitidis SOD (orange; PDB code: 2AQN), loop class (L-class) M. tuberculosis SOD (cyan; 1025 
PDB code: 1PZS), E-class human SOD (HsSOD, green; PDB code 1PU0) dimers, and 1026 
crystallographic B. subtilis SOD-like dimer (magenta; PDB code: 1S4I), although this homolog 1027 
is monomeric in solution. For comparison, the buried dimer interface surface areas for SOD 1028 
homologs were computed with the PISA webserver (http://www.ebi.ac.uk/msd-srv/prot_int/cgi-1029 
bin/piserver): NmSOD (915 Å2), M. tuberculosis (1636 Å2), HsSOD (~704 Å2) and the B. 1030 
subtilis SOD-like homolog (~347 Å2). PISA predicts B. abortus SOD to be monomeric. 1031 
However, PISA also predicts the crystallographic BsSOD dimer to be stable. (B) NmSOD dimer 1032 
structure and surface, bisected at the dimer interface, highlights P-class dimer-specific residues 1033 
(red), which are located around the perimeter of the water-filled cavity buried in the dimer 1034 
interface. Red residues correspond to red sequence motifs depicted in part C. Black star denotes 1035 
position of NmSOD-specific cavity adjacent to auxiliary Cu site (gold sphere). (C) Sequence 1036 
alignment representing 4 SOD assembly classes: BaSOD (P-class monomer), NmSOD (P-class 1037 
dimer), M. tuberculosis (L-class dimer) and HsSOD (E-class dimer). Bacterial sequences start at 1038 
the site of signal peptidase cleavage. Conserved sequence motifs (magenta, except where 1039 
indicated) include the leucine “cork,” (replaced by a single residue insertion in fungi) starting the 1040 
conserved LxxGxHG pattern, Cu ligands (gold H or gold/silver bridging H), Zn ligands 1041 
(gold/silver bridging H or silver D/H, missing in some L-class SODs), aspartic acid that 1042 
indirectly bridges Cu and Zn ligands via hydrogen bonds and the Rx(A/V)CGV(I/V) motif (near 1043 
Pratt et al.  N. meningitidis and B. abortus Cu,ZnSODs  48 
 
C-terminus), which includes both the conserved active-site arginine (italic R) and invariant 1044 
second cysteine of conserved disulfide bond. Discriminating features of E-class SODs include: 1045 
conserved residues involved in electrostatic guidance (indicated by purple italics), first cysteine 1046 
of conserved disulfide bond (light green C) located 6 residues before bridging histidine and an 1047 
aromatic or hydrophobic interface residue (yellow F, followed by G) located 2 residues after the 1048 
second Cu ligand (Cu2). Discriminating features of bacterial SODs include:  distinct residues 1049 
implicated in electrostatic guidance (purple italics in boxed sequence), first cysteine of conserved 1050 
disulfide bond (green C) located 5 residues after Cu2, an insertion ~7 residues after Cu2 in P-1051 
class SODs, and an insertion ~10 residues after the fourth Cu ligand (Cu4) in L-class SODs. 1052 
Discriminating features in P-class dimers, but not monomers (red lettering), include: a semi-1053 
conserved YG motif, located 11 residues N-terminal to the conserved leucine cork; a 1054 
hydrophobic residue (typically V or L; V in NmSOD) 8 residues before the leucine cork; a 1055 
hydrophobic residue, preceded by glycine, substituted in monomers with a residue capable of 1056 
hydrogen-bonding, located ~4 residues after the cork leucine (L in NmSOD); an aromatic 1057 
tryptophan or tyrosine in P-class SOD dimers 7-8 residues before conserved aspartate (Zn ligand 1058 
in many SODs) substituted to a charged residue in other classes (W in NmSOD). Protective (red 1059 
bar) and non-protective (orange bars) peptide immunogens (48) are mapped below the BaSOD 1060 
sequence. Approximate position of conserved secondary structural elements are denoted below 1061 
sequences as arrows (β-strands) and coils (α-helices). The blue arrows denote P-class secondary 1062 
structure in bacterial-specific insertion, and the turquoise coil denotes a L- and P-class-specific 1063 
secondary structure feature.  1064 
 1065 
FIG 4 Role of NmSOD residues in Cu binding and activity. (A) Identification of electrostatic 1066 
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guidance residues in NmSOD. The reaction rate constant for NmSOD electrostatics mutants as a 1067 
function of pH was evaluated using pulse radiolysis. Whereas the E73A mutation has no effect 1068 
on the reaction rate constant, reversing or neutralizing the charge at both proposed electrostatic 1069 
residues K91 and K94, caused a substantial decrease in the reaction rate constant. (B) NmSOD 1070 
E73 contributes to protein stability, as assayed by monitoring guanidine-HCl unfolding of WT 1071 
and E73A NmSOD, and WT HsSOD, with circular dichroism (CD) spectroscopy. The unfolding 1072 
midpoint for the E73A mutant is approximately 0.6-0.7 M lower than for WT NmSOD. Asterisks 1073 
denote data points omitted from the fitting. (C) Close-up looking down the two-fold dimer axis 1074 
of WT NmSOD (top). The E73 and H133 side chains from each subunit of the dimer are 1075 
positioned with tetrahedral coordination geometry around the Cu ion. Auxiliary Cu binding was 1076 
abrogated in E73A mutant (bottom), wherein only solvent molecules are observed at the 1077 
equivalent site. (D) Superposition of NmSOD and heme-bound HdSOD (PDB code: 1Z9P) 1078 
reveals parallel structure and dimer assembly. (E) Zoom into binding site (dashed box in part D) 1079 
reveals similarities in Cu binding by NmSOD E73 and H133 as compared to heme binding by 1080 
HdSOD H64 and H124.  1081 
 1082 
FIG 5 Potential roles of NmSOD auxiliary Cu site. (A) Overview (top) and close-up views 1083 
(bottom) of binding pocket below NmSOD auxiliary Cu site. Surface rendering suggested pocket 1084 
volume (124.6 Å3) could accommodate small molecules. (B) Suggested mechanisms for 1085 
virulence utilized in NmSOD upon phagocytosis. NmSOD counters reactive oxygen species 1086 
through its dismutase activity and buffers toxic Cu influx through its cross-dimer Cu binding 1087 
site. 1088 
 1089 
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FIG 6 Immunogen extension from new SOD structures. (A) Comparison of NmSOD and 1090 
BaSOD with HsSOD. Identical residues (magenta) were mapped onto superposed HsSOD (light 1091 
gray) with NmSOD (gold, left) or BaSOD (blue, right) molecular surfaces. Despite the large 1092 
evolutionary separation between bacterial and mammalian SODs, BaSOD and NmSOD contain 1093 
many residues identical to HsSOD, predominantly near the active site. (B) Cα atomic 1094 
displacement parameters (ADP; B-factor) for NmSOD and BaSOD are plotted by residue. 1095 
Increased mobility was noted predominantly in two regions specific to bacterial SODs (an 1096 
extended loop, green, and a bacterial insertion, red). These two regions were similarly suggested 1097 
to be mobile using normal mode analysis. Superimposed normal mode analysis models (from 1098 
Fig. S2) are inset in plot for NmSOD (top, gold) and BaSOD (bottom, blue). (C) Superposition 1099 
of single subunits from bacterial SOD (NmSOD, gold, left or BaSOD, blue, center) and HsSOD 1100 
(gray) crystallographic structures also reveals that the afore-mentioned insertions/loops 1101 
characteristic of bacterial SODs are non-conserved regions in 3-dimensional space. These 1102 
potential immunogens were mapped onto aligned SOD subunits (right) in red and green. 1103 






